Roivant Sciences (ROIV) Short Interest Ratio & Short Volume $11.98 -0.02 (-0.13%) As of 10:53 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Roivant Sciences Short Interest DataRoivant Sciences (ROIV) has a short interest of 38.31 million shares, representing 9.55% of the float (the number of shares available for trading by the public). This marks a -9.56% decrease in short interest from the previous month. The short interest ratio (days to cover) is 6.7, indicating that it would take 6.7 days of the average trading volume of 5.72 million shares to cover all short positions.Current Short Interest38,310,000 sharesPrevious Short Interest42,360,000 sharesChange Vs. Previous Month-9.56%Dollar Volume Sold Short$435.20 millionShort Interest Ratio6.7 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares682,880,000 sharesFloat Size401,310,000 sharesShort Percent of Float9.55%Today's Trading Volume335,157 sharesAverage Trading Volume5,716,881 sharesToday's Volume Vs. Average6% Short Selling Roivant Sciences? Sign up to receive the latest short interest report for Roivant Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartROIV Short Interest Over TimeROIV Days to Cover Over TimeROIV Percentage of Float Shorted Over Time Roivant Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/202538,310,000 shares $435.20 million -9.6%9.6%6.7 $11.36 7/15/202542,360,000 shares $481.21 million +3.1%10.6%6.9 $11.36 6/30/202541,100,000 shares $463.20 million -8.8%10.2%6.3 $11.27 6/15/202545,060,000 shares $510.08 million +1.4%10.8%7 $11.32 5/31/202544,430,000 shares $487.84 million -9.8%10.6%6.7 $10.98 5/15/202549,230,000 shares $529.71 million -6.7%11.2%7.6 $10.76 4/30/202552,740,000 shares $612.84 million +3.0%12.0%8 $11.62 4/15/202551,230,000 shares $515.37 million +13.6%11.7%8.5 $10.06 3/31/202545,100,000 shares $455.06 million -13.4%10.3%7.7 $10.09 3/15/202552,090,000 shares $555.28 million +12.9%11.9%9.8 $10.66 Get the Latest News and Ratings for ROIV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Roivant Sciences and its competitors with MarketBeat's FREE daily newsletter. 2/28/202546,140,000 shares $495.54 million +8.8%10.4%10 $10.74 2/15/202542,400,000 shares $447.74 million +0.5%9.6%9.2 $10.56 1/31/202542,200,000 shares $469.69 million -6.0%9.4%8.8 $11.13 1/15/202544,880,000 shares $496.82 million +3.2%10.0%9.6 $11.07 12/31/202443,500,000 shares $514.61 million -1.6%11.5%9.4 $11.83 12/15/202444,200,000 shares $523.33 million -7.6%11.8%8.7 $11.84 11/30/202447,810,000 shares $607.67 million +10.3%12.6%8 $12.71 11/15/202443,350,000 shares $485.52 million -6.9%11.5%6.9 $11.20 10/31/202446,570,000 shares $537.88 million -7.2%12.4%8 $11.55 10/15/202450,190,000 shares $596.26 million -2.0%13.3%8.5 $11.88 9/30/202451,220,000 shares $591.08 million +52.6%13.6%8.3 $11.54 9/15/202433,570,000 shares $400.83 million -12.2%9.0%5.5 $11.94 8/31/202438,220,000 shares $467.43 million -6.6%8.6%7.7 $12.23 8/15/202440,900,000 shares $462.58 million -1.7%9.2%8.2 $11.31 7/31/202441,600,000 shares $451.36 million +1.8%9.3%8.5 $10.85 7/15/202440,850,000 shares $469.78 million -8.7%8.4%8.4 $11.50 6/30/202444,760,000 shares $473.11 million +11.7%8.8%9.2 $10.57 6/15/202440,070,000 shares $428.35 million +8.3%7.9%5.9 $10.69 5/31/202437,000,000 shares $383.32 million -5.0%7.3%5.5 $10.36 5/15/202438,930,000 shares $447.70 million -14.6%7.0%6 $11.50 4/30/202445,580,000 shares $496.82 million +1.0%8.3%6.6 $10.90 4/15/202445,130,000 shares $489.21 million +45.9%8.2%6.2 $10.84 3/31/202430,930,000 shares $326.00 million -2.0%5.6%4.2 $10.54 3/15/202431,570,000 shares $320.12 million +14.0%6.6%5.9 $10.14 2/29/202427,690,000 shares $316.77 million -3.8%5.8%5.1 $11.44 2/15/202428,770,000 shares $329.42 million +11.9%6.0%5.3 $11.45 1/31/202425,710,000 shares $257.10 million -19.6%5.4%4.8 $10.00 1/15/202431,990,000 shares $353.81 million +2.9%5.8%5.4 $11.06 12/31/202331,080,000 shares $349.03 million +9.3%5.7%5.3 $11.23 12/15/202328,440,000 shares $317.39 million -6.6%5.2%4.1 $11.16What Steve Bannon revealed about Trump’s gold play (Ad)A Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your IRA could be at risk. Here’s how to prepare.Download the Free Gold Protection Guide to get started now 11/30/202330,440,000 shares $291.01 million +1.9%5.6%4.6 $9.56 11/15/202329,870,000 shares $270.92 million -10.1%5.5%4.6 $9.07 10/31/202333,230,000 shares $287.11 million -6.3%6.2%5.2 $8.64 10/15/202335,460,000 shares $357.44 million +10.9%6.7%6.3 $10.08 9/30/202331,990,000 shares $373.64 million +74.4%6.1%6 $11.68 9/15/202318,340,000 shares $207.06 million -13.5%3.6%3.7 $11.29 8/31/202321,190,000 shares $245.17 million +3.9%4.9%4.2 $11.57 8/15/202320,390,000 shares $223.68 million -3.4%4.7%4.1 $10.97 7/31/202321,100,000 shares $252.78 million +0.8%4.9%4.5 $11.98 7/15/202320,940,000 shares $244.37 million -9.0%4.8%4.5 $11.67 6/30/202323,000,000 shares $231.84 million +42.5%5.3%5.2 $10.08 6/15/202316,140,000 shares $160.11 million +14.0%3.9%4.2 $9.92 5/31/202314,160,000 shares $128.71 million -1.6%3.4%4.4 $9.09 5/15/202314,390,000 shares $131.67 million +2.6%3.5%4.8 $9.15 4/30/202314,020,000 shares $119.87 million -4.1%3.4%4.8 $8.55 4/15/202314,620,000 shares $103.95 million +5.3%3.6%5 $7.11 3/31/202313,880,000 shares $102.43 million +32.8%3.4%5.1 $7.38 3/15/202310,450,000 shares $89.77 million -1.7%2.6%3.7 $8.59 2/28/202310,630,000 shares $86.00 million -0.5%2.7%4.4 $8.09 2/15/202310,680,000 shares $95.05 million -16.8%2.8%4.4 $8.90 1/31/202312,830,000 shares $106.49 million -26.4%3.5%5.5 $8.30 1/15/202317,420,000 shares $171.94 million +6.2%4.8%7.9 $9.87 12/30/202216,400,000 shares $131.04 million +15.7%4.5%8.2 $7.99 12/15/202214,180,000 shares $102.66 million +12.5%3.9%8.4 $7.24 11/30/202212,610,000 shares $67.59 million +2.6%3.6%8.8 $5.36 11/15/202212,290,000 shares $68.09 million -0.2%3.5%10.4 $5.54 10/31/202212,310,000 shares $63.27 million +5.4%3.6%11 $5.14 10/15/202211,680,000 shares $53.49 million +3.6%3.4%13 $4.58 9/30/202211,270,000 shares $36.29 million +8.3%3.3%12.9 $3.22 9/15/202210,410,000 shares $36.44 million +4.5%3.1%11.9 $3.50 8/31/20229,960,000 shares $35.46 million +6.5%2.9%11 $3.56 8/15/20229,350,000 shares $39.74 million +9.2%2.8%8.9 $4.25 7/31/20228,560,000 shares $34.07 million +5.0%2.5%8.5 $3.98 7/15/20228,150,000 shares $34.80 million +24.8%2.4%8.6 $4.27 6/30/20226,530,000 shares $26.58 million +9.8%2.0%7.1 $4.07 6/15/20225,950,000 shares $23.98 million +65.3%1.8%7.4 $4.03 5/31/20223,600,000 shares $15.98 million +60.0%1.1%5.1 $4.44 5/15/20222,250,000 shares $7.79 million -1.3%0.7%4.6 $3.46 4/30/20222,280,000 shares $8.41 million -4.2%0.7%5.8 $3.69 4/15/20222,380,000 shares $9.64 million -18.2%0.7%5.9 $4.05 3/31/20222,910,000 shares $14.38 million +3.2%0.9%7.7 $4.94 3/15/20222,820,000 shares $14.64 million -4.4%0.9%6.9 $5.19 2/28/20222,950,000 shares $18.56 million +0.7%0.9%5.1 $6.29 2/15/20222,930,000 shares $21.15 million +7.3%0.9%4.2 $7.22 1/31/20222,730,000 shares $18.24 million +4.2%0.8%3.7 $6.68 1/15/20222,620,000 shares $20.83 million +12.5%0.8%3.4 $7.95 12/31/20212,330,000 shares $23.49 million No Change0.7%3 $10.08 ROIV Short Interest - Frequently Asked Questions What is Roivant Sciences' current short interest? Short interest is the volume of Roivant Sciences shares that have been sold short but have not yet been closed out or covered. As of July 31st, investors have sold 38,310,000 shares of ROIV short. 9.55% of Roivant Sciences' shares are currently sold short. Learn More on Roivant Sciences' current short interest. What is a good short interest ratio for Roivant Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ROIV shares currently have a short interest ratio of 7.0. Learn More on Roivant Sciences's short interest ratio. Which institutional investors are shorting Roivant Sciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Roivant Sciences: Exome Asset Management LLC, Group One Trading LLC, Jane Street Group LLC, Walleye Capital LLC, Walleye Trading LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Roivant Sciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.55% of Roivant Sciences' floating shares are currently sold short. Is Roivant Sciences' short interest increasing or decreasing? Roivant Sciences saw a decline in short interest during the month of July. As of July 31st, there was short interest totaling 38,310,000 shares, a decline of 9.6% from the previous total of 42,360,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Roivant Sciences' float size? Roivant Sciences currently has issued a total of 682,880,000 shares. Some of Roivant Sciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Roivant Sciences currently has a public float of 401,310,000 shares. How does Roivant Sciences' short interest compare to its competitors? 9.55% of Roivant Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Roivant Sciences: BioNTech SE Sponsored ADR (2.56%), Insmed, Inc. (4.65%), Teva Pharmaceutical Industries Ltd. (4.37%), Summit Therapeutics PLC (27.63%), Genmab A/S Sponsored ADR (0.58%), Viatris Inc. (3.26%), Ascendis Pharma A/S (7.52%), Dr. Reddy's Laboratories Ltd (1.21%), QIAGEN N.V. (3.07%), Moderna, Inc. (18.29%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Roivant Sciences stock? Short selling ROIV is an investing strategy that aims to generate trading profit from Roivant Sciences as its price is falling. ROIV shares are trading up $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Roivant Sciences? A short squeeze for Roivant Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ROIV, which in turn drives the price of the stock up even further. How often is Roivant Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ROIV, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies BioNTech Short Interest Data Insmed Short Interest Data Teva Pharmaceutical Industries Short Interest Data Summit Therapeutics Short Interest Data Genmab A/S Short Interest Data Viatris Short Interest Data Ascendis Pharma A/S Short Interest Data Dr. Reddy's Laboratories Short Interest Data QIAGEN Short Interest Data Moderna Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ROIV) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roivant Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Roivant Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access